Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462917 · ClinicalTrials.gov registry record · NA
REVEAL III: Risk Evaluation and Education for Alzheimer's Disease
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
NCT00462917: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT00462917 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 290 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00462917, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
Study Summary
The purpose of this study is to provide healthy adults with genetic testing and information about their chances of developing Alzheimer's disease.
Primary Outcome
A 20-item scale measuring general depression. Scores range from 0-60, with higher scores indicating greater general depression.
Interventions
- BEHAVIORAL Pleiotropic info, in-person disclosure
- BEHAVIORAL AD-only info, in-person disclosure
- BEHAVIORAL Pleiotropic info, phone disclosure
- BEHAVIORAL AD-only info, phone disclosure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00462917 record still lists
NCT00462917 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 4 interventions - of which Pleiotropic info, in-person disclosure is the first listed.
NCT00462917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00462917 about?
NCT00462917 is a clinical study titled "REVEAL III: Risk Evaluation and Education for Alzheimer's Disease". The purpose of this study is to provide healthy adults with genetic testing and information about their chances of developing Alzheimer's disease.
What is the current status of trial NCT00462917?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2007-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00462917?
The interventions under investigation include: Pleiotropic info, in-person disclosure (BEHAVIORAL), AD-only info, in-person disclosure (BEHAVIORAL), Pleiotropic info, phone disclosure (BEHAVIORAL), AD-only info, phone disclosure (BEHAVIORAL).
Who is sponsoring clinical trial NCT00462917?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00462917's enrollment target sits among peer trials
290 375th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia